Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Forward Management Bet Big On These REITs Ahead Of Its Merger With Salient

Page 1 of 2

San Francisco-based Forward Management, led by J. Alan Reid, Jr., is a multi-strategy fund, investing primarily in growth and value stocks of small and mid-cap companies. The fund, which has $4.5 billion in assets under management, is now merging with Salient Partners, which acquired the fund in a deal, the terms of which were not disclosed. The merger of both businesses will result in a combined $27-billion diversified asset management firm, led by John Blaisdell as chairman and Chief Executive Officer. Salient Partners intends to complete the integration and optimization process of the businesses over the coming months. In its latest, now to be final, 13Ffiled with the U.S. Securities and Exchange Commission, Forward Management disclosed a public equity portfolio mainly consisting of finance (which includes real estate) stocks, with an aggregate value of $1.67 billion. We have picked the top stocks from that filing to discuss in this article as we wish the Forward Management team all the best in their new arrangement. The final top holdings of the fund are represented by Chatham Lodging Trust (NYSE:CLDT), Franklin Street Properties Corp. (NYSEMKT:FSP), and Stag Industrial Inc (NYSE:STAG).

Alan Reid Forward Management

We track hedge funds to learn about their investment ideas. Our research has shown that hedge funds’ large-cap stock picks historically delivered a monthly alpha of six basis points, though these stocks underperformed the S&P 500 Total Return Index by an average of seven basis points per month between 1999 and 2012.  On the other hand, the 15 most popular small-cap stocks among hedge funds outperformed the S&P 500 Index by an average of 95 basis points per month. These stocks were slightly riskier, so their monthly alpha was 80 basis points (read the details here). Since the official launch of our small-cap strategy in August 2012 it has performed just as predicted, returning over 142% and beating the market by more than 83 percentage points.

Coming back to top picks of Forward Management, we’ll first discuss Chatham Lodging Trust (NYSE:CLDT), in which the fund increased its stake by 8% to 1.85 million shares, valued at $54.4 million during the first quarter. Chatham Lodging Trust (NYSE:CLDT) is a lodging real estate investment trust (REIT) that invests in upscale, extended-stay hotels, and has a market cap of $1.05 billion. For the first quarter of 2015, Chatham Lodging Trust (NYSE:CLDT) reported net income of $1.42 million, versus a loss of $1.73 million in the same quarter last year. Among the most notable moves of the company in the first quarter was the acquisition of the 240-suite Residence Inn San Diego Downtown-Gaslamp District hotel. The company paid $90 million for the hotel, located near Petco Park, the home of MLB’s San Diego Padres, and the Westfield Horton shopping complex. In the beginning of this year, Chatham Lodging Trust (NYSE:CLDT) announced an increase to its monthly dividend of 25%, to $0.10 per share, or $1.20 per share on an annualized basis, for a 4.38% yield. Chatham Lodging Trust (NYSE:CLDT)’s stock gained 19.43% during the past calendar year, compared to the industry average of 11.58%. The largest shareholder of the company after Forward Management among the funds and investors we track is Jeffrey Furber’s AEW Capital Management, which held 1.36 million shares as of March 31.

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!